Green Park & Golf Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol).
BiotechHealthtechMedical DevicesTarpon Springs, US
Oliver Schlueter(Executive Officer, Director)Barry Butler(Founder & Chief Executive Officer)Oliver Schluter(Executive Officer, Director)Oliver Schlüter(Chief Financial Officer)Ronil Patel(Chief Operating Officer)Haley Lemon(Executive Officer)
Co-investorsEvolution VC Partners
EarthView develops BluBird, a continuous emissions monitoring system that detects, locates, and quantifies gas leaks in real time.
CleantechClimate TechDeep TechEnergyHardwareDallas, US
Bear Givhan(Co-founder & CEO)Jim Maslanik(Co-founder & Chief Scientist)John Reed(Executive Officer, Director)Frederick Bear Givhan(Executive Officer, Director)Kevin Yoon(VP of Product)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.